INDSWIFT LABORATORIES
Back to Cashflow Statement
|
INDSWIFT LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹69 Cr | ₹681 Cr | ₹-186 Cr | ₹-141 Cr | ₹-124 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDSWIFT LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹69 Cr |
| Mar2024 | ₹681 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹-141 Cr |
| Mar2021 | ₹-124 Cr |
How is Cash Flow from Financing Activities of INDSWIFT LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹69 Cr | -89.83 | |
| Mar2024 | ₹681 Cr | Positive | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹-141 Cr | Negative | |
| Mar2021 | ₹-124 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹763.2 Cr | -1.8% | -3.5% | -17.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,705.0 Cr | -0.7% | 2% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,091.0 Cr | -2.1% | -2.8% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,555.0 Cr | -0.9% | -0.6% | 12.2% | Stock Analytics | |
| CIPLA | ₹120,919.0 Cr | -1% | -1.2% | 3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,165.0 Cr | -0.1% | 2.3% | 2.6% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | -1.8% |
-3.5% |
-17.2% |
| SENSEX | 0.2% |
-0.5% |
4% |
You may also like the below Video Courses